Obama administration is considering streamlining the approval process for antibiotics . The move would allow more drugs to be used in animals without requiring a costly and lengthy review by federal regulators. For patients with life-threatening infections , access to new antibiotics is vital . She says by limiting their use to the sickest of the sick , we can minimize risks of new drugs . A proposal from the Infectious Diseases Society of America aims to address a key part of the problem by reducing the obstacles to regulatory approval of new antibiotics for use in a distinct , narrow group of people : Boucher : We need to encourage more companies to do antibiotic research and development .
Obama administration is considering streamlining the approval process for antibiotics . The move would allow more drugs to be used in animals without requiring a costly and lengthy review by federal regulators. For patients with life-threatening infections , access to new antibiotics is vital . She says by limiting their use to the sickest of the sick , we can minimize risks of new drugs . Boucher : We need to encourage more companies to do antibiotic research and development .